142 related articles for article (PubMed ID: 3316581)
1. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease.
Stiller CR; Dupre J; Gent M; Heinrichs D; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; Wolfe BM
J Pediatr; 1987 Dec; 111(6 Pt 2):1069-72. PubMed ID: 3316581
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
Stiller CR; Dupré J; Gent M; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; von Graffenried B; Wolfe BM
Science; 1984 Mar; 223(4643):1362-7. PubMed ID: 6367043
[TBL] [Abstract][Full Text] [Related]
3. Induction and pathophysiology of remission of insulin-dependent diabetes mellitus during administration of ciclosporin. London Diabetes Study Group.
Dupre J; Hramiak I; Mahon JL; Stiller CR
Horm Res; 1990; 33(2-4):152-8. PubMed ID: 2210620
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
Feutren G
Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
[No Abstract] [Full Text] [Related]
5. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with early remission of type I diabetes in children treated with cyclosporine.
Bougneres PF; Carel JC; Castano L; Boitard C; Gardin JP; Landais P; Hors J; Mihatsch MJ; Paillard M; Chaussain JL
N Engl J Med; 1988 Mar; 318(11):663-70. PubMed ID: 3125434
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine in insulin-dependent diabetes mellitus.
Bach JF
J Pediatr; 1987 Dec; 111(6 Pt 2):1073-4. PubMed ID: 3316582
[No Abstract] [Full Text] [Related]
8. [Immunopathogenesis and immunotherapy of type 1 diabetes mellitus].
Pietschmann P; Schernthaner G
Z Med Lab Diagn; 1989; 30(1):61-2. PubMed ID: 2655327
[No Abstract] [Full Text] [Related]
9. [Cyclosporin A in type I diabetes mellitus].
Kolb H
Internist (Berl); 1985 Sep; 26(9):580-1. PubMed ID: 3905682
[No Abstract] [Full Text] [Related]
10. Cyclosporine trials in diabetes: updated results of the French experience.
Assan R; Feutren G; Sirmai J
Transplant Proc; 1988 Jun; 20(3 Suppl 4):178-83. PubMed ID: 3289203
[No Abstract] [Full Text] [Related]
11. [Cyclosporin in autoimmune diseases].
Frey FJ
Schweiz Med Wochenschr; 1990 May; 120(21):772-86. PubMed ID: 2190313
[TBL] [Abstract][Full Text] [Related]
12. The effect of cyclosporine A on humoral and cellular immunity in insulin-dependent (type I) diabetes mellitus.
Boitard C; Debray-Sachs M; Chatenoud L; Bach JF
Transplant Proc; 1988 Jun; 20(3 Suppl 4):193-6. PubMed ID: 3289205
[No Abstract] [Full Text] [Related]
13. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
Feutren G; Mihatsch MJ
N Engl J Med; 1992 Jun; 326(25):1654-60. PubMed ID: 1588978
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.
Martin S; Schernthaner G; Nerup J; Gries FA; Koivisto VA; Dupré J; Standl E; Hamet P; McArthur R; Tan MH
Diabetologia; 1991 Jun; 34(6):429-34. PubMed ID: 1884902
[TBL] [Abstract][Full Text] [Related]
15. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of cyclosporine in autoimmune diseases.
Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
[No Abstract] [Full Text] [Related]
17. Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months.
Dupré J; Stiller CR; Gent M; Donner A; von Graffenreid B; Murphy G; Heinrichs D; Jenner MR; Keown PA; Laupacis A
Transplant Proc; 1988 Jun; 20(3 Suppl 4):184-92. PubMed ID: 3289204
[No Abstract] [Full Text] [Related]
18. Renal changes associated with cyclosporine in recent type I diabetes mellitus.
Rodier M; Ribstein J; Parer-Richard C; Mimran A
Hypertension; 1991 Sep; 18(3):334-40. PubMed ID: 1889846
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine: therapeutic effects in rheumatic diseases.
Amor B; Dougados M
Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
[No Abstract] [Full Text] [Related]
20. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
Palestine AG; Austin HA; Nussenblatt RB
Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
